Biofourmis procures $100m Series C

Biofourmis, a provider of digital therapeutics that powers personalized predictive care, has closed $100 million in Series C financing.

3 September 2020•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles